New York State Common Retirement Fund’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
Other funds holding DSGN
CUAMC
AA
SO
OC
AA
YIH
PFSRSONJ
GI
New York State Common Retirement Fund's DSGN Position: Q2 2026 in Review
New York State Common Retirement Fund increased its Design Therapeutics (DSGN) stake by 434% in Q2 2026, buying an estimated $110K and bringing the position to 10,826 shares worth $157K. The position accounts for ﹤0.01% of the portfolio, ranked #2471.
New York State Common Retirement Fund first reported a position in DSGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $405K in Q3 2022. 23 funds tracked by Wall St. Rank hold DSGN as of Q2 2026.
- New York State Common Retirement Fund held 10,826 shares of Design Therapeutics worth $157K as of Q2 2026.
- New York State Common Retirement Fund bought 8,800 Design Therapeutics shares in Q2 2026, an estimated $110K.
- Design Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2471 holding.
- New York State Common Retirement Fund first reported a position in Design Therapeutics in Q2 2021 and has held it in 21 quarters since.
- New York State Common Retirement Fund's Design Therapeutics position peaked at $405K in Q3 2022.
- 23 funds tracked by Wall St. Rank held Design Therapeutics as of Q2 2026.
Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.